USP30-AS1: A Potential Drug Target and Biomarker (G100131733)

USP30-AS1: A Potential Drug Target and Biomarker

The USP30 family of proteins plays a crucial role in the regulation of cell growth, differentiation, and survival. USP30-AS1, a member of the USP30 family, is a protein that has been identified as a potential drug target and biomarker. In this article, we will explore the biology of USP30-AS1, its potential as a drug target, and its potential as a biomarker for various diseases.

The USP30 family of proteins is characterized by the presence of a unique catalytic domain and a N-terminal hypervariable region (HVR). The catalytic domain is known as the alpha-helices domain, which is a structural feature that is common to many proteins that are involved in cell signaling pathways. The N-terminal HVR is unique to the USP30 family and is involved in the regulation of protein stability and localization.

USP30-AS1 is a 21-kDa protein that is expressed in a variety of tissues, including brain, heart, and pancreas. It is localized to the endoplasmic reticulum (ER) and is involved in the regulation of protein stability and localization. USP30-AS1 has been shown to play a role in the regulation of cell growth, differentiation, and survival.

As a potential drug target, USP30-AS1 is of interest because of its involvement in cell signaling pathways. It has been shown to play a role in the regulation of cell adhesion, migration, and the process of apoptosis. USP30-AS1 has also been shown to interact with several other proteins, including the transcription factor, NF-kappa-B, and the protein kinase, PKA. These interactions may provide a target for small molecules that can modulate its function and activity.

As a potential biomarker, USP30-AS1 is of interest because of its involvement in the regulation of protein stability and localization. It has been shown to play a role in the regulation of protein stability and localization in the ER. This may provide a target for small molecules that can modulate its function and activity.

In conclusion, USP30-AS1 is a protein that has been identified as a potential drug target and biomarker. Its role in the regulation of cell growth, differentiation, and survival makes it of interest for further study. Further research may reveal its mechanisms of action and identify small molecules that can modulate its function and activity.

Protein Name: USP30 Antisense RNA 1

The "USP30-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP30-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8 | USP8P1 | USP9X | USP9Y | USPL1 | UST | UTF1 | UTP11 | UTP14A | UTP14C | UTP15 | UTP18 | UTP20 | UTP23 | UTP25 | UTP3 | UTP4 | UTP6 | UTRN | UTS2 | UTS2B | UTS2R | UTY | UVRAG | UVSSA | UXS1 | UXT | UXT-AS1 | VAC14 | Vacuolar H+ ATPase | VAMP1 | VAMP2 | VAMP3 | VAMP4 | VAMP5 | VAMP7 | VAMP8 | VANGL1 | VANGL2 | VAPA | VAPB | VARS1 | VARS2 | Vascular endothelial growth factor receptor (VEGFR) | Vascular endothelial growth factors (VEGF) | VASH1 | VASH1-AS1 | VASH2 | VASN | Vasoactive intestinal polypeptide receptor (VIP-R) | Vasohibin | Vasopressin Receptor | Vasopressin V1 Receptor | VASP | VAT1 | VAT1L | VAV1 | VAV2 | VAV3 | VAV3-AS1 | VAX1 | VAX2 | VBP1 | VCAM1 | VCAN | VCL | VCP